Display options
Cite
Monzen S, Mariya Y, Wojcik A, et al. Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients. Mol Clin Oncol. 2015;3(3):692-698doi: 10.3892/mco.2015.499.
Monzen, S., Mariya, Y., Wojcik, A., Kawamura, C., Nakamura, A., Chiba, M., Hosoda, M., & Takai, Y. (2015). Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients. Molecular and clinical oncology, 3(3), 692-698. https://doi.org/10.3892/mco.2015.499
Monzen, Satoru, et al. "Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients." Molecular and clinical oncology vol. 3,3 (2015): 692-698. doi: https://doi.org/10.3892/mco.2015.499
Monzen S, Mariya Y, Wojcik A, Kawamura C, Nakamura A, Chiba M, Hosoda M, Takai Y. Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients. Mol Clin Oncol. 2015 May;3(3):692-698. doi: 10.3892/mco.2015.499. Epub 2015 Jan 27. PMID: 26137289; PMCID: PMC4471615.
Copy Download .nbib Format: NLM
Share it on

Mol Clin Oncol. 2015 May;3(3):692-698. doi: 10.3892/mco.2015.499. Epub 2015 Jan 27.

Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients.

Molecular and clinical oncology

Satoru Monzen, Yasushi Mariya, Andrzej Wojcik, Chika Kawamura, Ayumi Nakamura, Mitsuru Chiba, Masahiro Hosoda, Yoshihiro Takai

Affiliations

  1. Department of Radiological Life Sciences, Division of Medical Life Sciences, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
  2. Centre for Radiation Protection Research, MBW Department, Stockholm University, SE-106 91 Stockholm, Sweden.
  3. Department of Biomedical Sciences, Division of Medical Life Sciences, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036-8564, Japan.
  4. Department of Radiology and Radiation Oncology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.

PMID: 26137289 PMCID: PMC4471615 DOI: 10.3892/mco.2015.499

Abstract

Radioactive iodine (

Keywords: cytotoxic damage; differentiated thyroid cancer; micronuclei; predictive factors; radioactive iodine therapy

References

  1. Mutat Res. 2002 Feb 15;514(1-2):77-85 - PubMed
  2. Int J Radiat Biol. 2011 May;87(5):491-8 - PubMed
  3. J Clin Endocrinol Metab. 2007 Sep;92(9):3542-6 - PubMed
  4. Iran J Ped Hematol Oncol. 2013;3(2):73-7 - PubMed
  5. Hum Mol Genet. 2008 Oct 15;17 (20):3247-53 - PubMed
  6. Eur J Nucl Med Mol Imaging. 2004 May;31(5):676-84 - PubMed
  7. Eur J Intern Med. 2013 Apr;24(3):241-4 - PubMed
  8. Oncol Rep. 2012 Jul;28(1):55-61 - PubMed
  9. Neoplasma. 2013;60(5):568-75 - PubMed
  10. Tohoku J Exp Med. 2013;229(2):115-24 - PubMed
  11. Eur Rev Med Pharmacol Sci. 2013 Sep;17(17):2350-3 - PubMed
  12. Int J Hematol. 2002 Aug;76(2):157-64 - PubMed
  13. Radiat Res. 2010 Feb;173(2):184-90 - PubMed
  14. Ann Nucl Med. 2013 Oct;27(8):700-9 - PubMed
  15. Ann Nucl Med. 2012 Nov;26(9):744-51 - PubMed
  16. Eur J Nucl Med. 1999 Dec;26(12):1589-96 - PubMed
  17. J Clin Invest. 2013 Apr;123(4):1492-500 - PubMed
  18. Radiat Res. 2009 Sep;172(3):314-20 - PubMed
  19. Radiat Prot Dosimetry. 2012 Nov;152(1-3):224-8 - PubMed
  20. Ann Hematol. 2014 May;93(5):753-60 - PubMed
  21. Radiat Res. 2007 Nov;168(5):545-51 - PubMed
  22. J Nucl Med. 1998 May;39(5):825-9 - PubMed
  23. J Nucl Med. 2004 Apr;45(4):608-11 - PubMed
  24. Thyroid. 2014 Jul;24(7):1088-95 - PubMed
  25. PLoS One. 2013;8(3):e59385 - PubMed
  26. Endocr Rev. 2012 Dec;33(6):920-80 - PubMed

Publication Types